Targeting the Pathways to Better Health

Our Mission

Intellikine is discovering and developing innovative, small molecule drugs that target signal transduction networks for the treatment of cancer, inflammation and autoimmune diseases. Learn More

Research & Development

We have built an unmatched drug discovery platform to identify and advance drug candidates against targets in the PI3K/Akt/mTOR signaling pathway and related pathways.

Learn More

Pipeline

Our pipeline programs include both novel isoform-selective and pathway-selective inhibitors of members of the PI3K/Akt/mTOR signaling network.

Learn More

Contact Us

Partnering with industry leaders is a key component of our growth strategy and is focused in two areas: pipeline opportunities and our PI3K/Akt/mTOR drug discovery platform.

Learn More